微创机器人-B(02252)早盘逆市上涨2.80%,现报22港元,成交额1.72亿港元。
近日,摩根大通发表研究报告,指微创机器人最近两个月大幅跑赢恒指达100%,主要受益于对人工智能(AI)及机器人概念的热潮,以及收窄亏损的进度,目标可在明年收支平衡。公司近期盈利预告及订单走势提升了市场对其扩张装置基地的信心,尤其是海外。该行将其对公司目标价由8.4港元大幅上调至19.3港元,维持“中性”评级。报告指出,曾在上周的专家会议中讨论包括自动化手术的外科手术机器人领域内AI技术的最新进展,指自动化手术的发展需要时间,仍需克服技术、伦理和法规方面的挑战;现阶段,AI主要用于辅助手术操作,例如精确导航、术中影像处理和机器人辅助技术,上述应用已经提高了手术效率和患者安全性,但仍然需要外科医生的监控和参与。
责任编辑:卢昱君
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.